(2S,5R,13AS)-2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE
UNII 45CN2ZAS2D
Substance Identification & Data
This profile provides standardized clinical and technical data for (2s,5r,13as)-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-n-((2,4,6-trifluorophenyl)methyl)-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 45CN2ZAS2D.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1616340-12-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H18F3N3O5 SOLUWJRYJLAZCX-GDLVEWKHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2s,5r,13as)-2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-n-((2,4,6-trifluorophenyl)methyl)-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.